1. Six more biotechs price public debuts just before the start of the weekend—Surprise pandemic lessons for pharma -- August FDA decisions for Axsome, Sanofi, Merck See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

CULTURE—What’s wrong here?

Discussion in 'Aerie Pharma' started by anonymous, Mar 25, 2021 at 6:39 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Just saw the rep in Vegas resigned. So many high performers are jumping ship. How is it that reps that never did much of anything got management roles or “new positions”?
     

  2. anonymous

    anonymous Guest

    they want people with no experience so they can just tell them what to do.
     
  3. anonymous

    anonymous Guest

    Evan what’s with all the people leaving? It’s constant! Aren’t you going to address this with everyone? Cmon be a leader and be transparent!!
     
  4. anonymous

    anonymous Guest

    Of course he isn’t. They don’t want anyone to know who leaves or why. We already know why.
     
  5. anonymous

    anonymous Guest

     
  6. anonymous

    anonymous Guest

    I don’t know why? Tell me
     
  7. anonymous

    anonymous Guest

    you don’t work here if you don’t know why… if you do work here it is definitely not in the Southeast…. With MZ’s big mouth trying to lead it is a wonder so many of us have stuck it out…
     
  8. anonymous

    anonymous Guest

    Do not posts personnel issues on the internet. Employment status is private information!
     
  9. anonymous

    anonymous Guest

    if you’ve been here since launch, you’re doomed.
    You can’t compete with 20 something yo robo-reps.
    That’s what management wants and they’re on a campaign.
     
  10. anonymous

    anonymous Guest

    It’s not that older reps can’t compete, it’s that tenured reps run from the opportunity to work here. They know better. Failing products will only be able to keep 20 somethings. It makes sense to hire them.
     
  11. anonymous

    anonymous Guest

    Hey Wajda you small brained child, keep your political emails and comments to yourself. All they do is show just how unintelligent you are!
     
  12. anonymous

    anonymous Guest

    thank you!!! This company is full of idiots
     
  13. anonymous

    anonymous Guest

    When you work for a company with a product that will never be more than max med therapy the answer is obviously just do more speaker dinners! Thanks leadership for showing us the way.
     
  14. anonymous

    anonymous Guest

    A territory vacancy is NOT a personnel issue you dope! There was no name or situation mentioned.
    The rep in that territory is an amazing person and a real lose to this organization. Over the past two months we lost 3 top performing reps, that went out of there way to help others succeed. Given recent hires and promotions , I’m very nervous about the future of this company.
     
  15. anonymous

    anonymous Guest

    Hyperemia unfortunately will always be a limiting factor.
     
  16. anonymous

    anonymous Guest

    KOL’s & specialists put all territories at a huge advantage. Major inequities amongst TAM’s but leadership will continue to turn a supposed blind eye and ask what could you do differently. How about don’t let your Allergan failures choose their geographic boundaries to tilt their territories. There are people getting things done here that have gotten more out of less but we will continue praising those with the advantages. These are meds driven by specialists, the more specialists the more opportunities to get used.
     
  17. anonymous

    anonymous Guest

    Mid year reviews...let’s see how subjective these become. Performance and results can be measured all the other stuff they’ll try to throw at you is if they have an agenda or not. Terrible leadership and quite a few terrible people in these positions!
     
  18. anonymous

    anonymous Guest

    The issue with the products being driven by mainly glaucoma specialists, is a real problem. Marketing has put together some very poor strategies and lacked clear direction over the years. Without expanding the base of prescribers to cornea specialists, general Ophthamologists & ODs these drugs will never do any better.
     
  19. anonymous

    anonymous Guest

    Why is there so much turnover?
    Why is management team so weak?
    Why do we never hear from sr management?
    Why do direct questions never get answers?
     
  20. anonymous

    anonymous Guest

    because the company sucks